These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 11352962)

  • 41. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
    Urban C; Benesch M; Pakisch B; Lackner H; Kerbl R; Schwinger W; Oberbauer R
    J Neurooncol; 1998 Aug; 39(1):71-80. PubMed ID: 9760072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
    Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
    Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tandem high-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuro-ectodermic tumors.
    Dufour C; Kieffer V; Varlet P; Raquin MA; Dhermain F; Puget S; Valteau-Couanet D; Grill J
    Pediatr Blood Cancer; 2014 Aug; 61(8):1398-402. PubMed ID: 24664937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
    Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
    J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
    Graham ML; Herndon JE; Casey JR; Chaffee S; Ciocci GH; Krischer JP; Kurtzberg J; Laughlin MJ; Longee DC; Olson JF; Paleologus N; Pennington CN; Friedman HS
    J Clin Oncol; 1997 May; 15(5):1814-23. PubMed ID: 9164190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
    Mason WP; Grovas A; Halpern S; Dunkel IJ; Garvin J; Heller G; Rosenblum M; Gardner S; Lyden D; Sands S; Puccetti D; Lindsley K; Merchant TE; O'Malley B; Bayer L; Petriccione MM; Allen J; Finlay JL
    J Clin Oncol; 1998 Jan; 16(1):210-21. PubMed ID: 9440745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
    Cohen BH; Zeltzer PM; Boyett JM; Geyer JR; Allen JC; Finlay JL; McGuire-Cullen P; Milstein JM; Rorke LB; Stanley P
    J Clin Oncol; 1995 Jul; 13(7):1687-96. PubMed ID: 7602359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
    Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ;
    J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
    Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant human granulocyte colony-stimulating factor infusion and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report.
    Chau WK; Lin CK; Chow MP; Wang SY; Liu JM; Ho CH; Chiu CF; Hsu HC; Tan TD; Chan WK
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):312-20. PubMed ID: 7530591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
    Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
    Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
    Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
    Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).
    White L; Kellie S; Gray E; Toogood I; Waters K; Lockwood L; Macfarlane S; Johnston H
    J Pediatr Hematol Oncol; 1998; 20(2):125-30. PubMed ID: 9544162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.